UBS OCONNOR LLC - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 77 filers reported holding TREACE MED CONCEPTS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$2,268,082
-21.2%
173,004
+53.8%
0.06%
-37.4%
Q2 2023$2,876,548
-21.5%
112,453
-22.7%
0.09%
-19.5%
Q1 2023$3,666,631
-99.9%
145,559
+9.7%
0.11%
+101.8%
Q3 2022$2,927,000,000
+47.2%
132,637
-4.3%
0.06%
+93.1%
Q2 2022$1,988,000,000138,6370.03%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 1,907,823$25,011,5602.31%
FORMULA GROWTH LTD 222,269$2,913,9470.99%
EMERALD MUTUAL FUND ADVISERS TRUST 1,193,939$15,652,5400.94%
EMERALD ADVISERS, LLC 1,473,281$19,314,7130.94%
Perceptive Advisors 1,834,060$24,044,5270.80%
NEXT CENTURY GROWTH INVESTORS LLC 512,738$6,721,9950.73%
OBERWEIS ASSET MANAGEMENT INC/ 355,600$4,661,9160.50%
Novo Holdings A/S 360,000$4,719,6000.35%
TimesSquare Capital Management, LLC 1,433,429$18,7920.29%
KORNITZER CAPITAL MANAGEMENT INC /KS 677,733$8,885,0800.18%
View complete list of TREACE MED CONCEPTS INC shareholders